Compressive stress-mediated p38 activation required for ERα + phenotype in breast cancer

Pauliina M. Munne, Lahja Martikainen, Iiris Räty, Kia Bertula, Nonappa, Janika Ruuska, Hanna Ala-Hongisto, Aino Peura, Babette Hollmann, Lilya Euro, Kerim Yavuz, Linda Patrikainen, Maria Salmela, Juho Pokki, Mikko Kivento, Juho Väänänen, Tomi Suomi, Liina Nevalaita, Minna Mutka, Panu KovanenMarjut Leidenius, Tuomo Meretoja, Katja Hukkinen, Outi Monni, Jeroen Pouwels, Biswajyoti Sahu, Johanna Mattson, Heikki Joensuu, Päivi Heikkilä, Laura L. Elo, Ciara Metcalfe, Melissa R. Junttila, Olli Ikkala, Juha Klefström^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Scientific › peer-review

26 Citations (Scopus)

88 Downloads (Pure)

2 results

Filter

Finished
PreClinica: Novel Preclinical Model for Breast Cancer Theraphy
Nonappa, N. (Principal investigator), Bertula, K. (Project Member) & Heilala, M. (Project Member)
01/09/2017 → 30/09/2020
Project: Business Finland: New business from research ideas (TUTLI)
HYBER: The Academy of Finland's Centre of Excellence in Molecular Engineering of Biosynthetic Hybrid Materials research (2014-2019)
Ikkala, O. (Principal investigator), Morits, M. (Project Member), Rissanen, S. (Project Member), Nonappa, N. (Project Member), Sanchez Sanchez, A. (Project Member), Bertula, K. (Project Member), Cherian, T. (Project Member), Haataja, J. (Project Member), Toivonen, M. (Project Member), Poutanen, M. (Project Member), Sohrabi, F. (Project Member), Hynninen, V. (Project Member) & Myllymäki, T. (Project Member)
01/01/2017 → 31/12/2019
Project: Academy of Finland: Other research funding

Compressive stress-mediated p38 activation required for ERα + phenotype in breast cancer

Projects

Search results

PreClinica: Novel Preclinical Model for Breast Cancer Theraphy

HYBER: The Academy of Finland's Centre of Excellence in Molecular Engineering of Biosynthetic Hybrid Materials research (2014-2019)